Halofantrine: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 26: Line 26:
'''| [[Halofantrine drug interactions|Drug Interactions]]'''
'''| [[Halofantrine drug interactions|Drug Interactions]]'''
'''| [[Halofantrine overdosage|Overdosage]]'''
'''| [[Halofantrine overdosage|Overdosage]]'''
'''| [[Halofantrine clinical studies|Clinical Studies]]'''
'''| [[Halofantrine dosage and administration|Dosage and Administration]]'''
'''| [[Halofantrine dosage and administration|Dosage and Administration]]'''
'''| [[Halofantrine how supplied|How Supplied]]'''
'''| [[Halofantrine how supplied|How Supplied]]'''
'''| [[Halofantrine labels and packages|Labels and Packages]]'''


==Mechanism of Action==
==Mechanism of Action==

Revision as of 03:01, 7 January 2014

Halofantrine
HALFAN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Halofantrine is a drug used to treat malaria. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It is never used to prevent malaria. Its mode of action is unknown.

Category

Antiparasitic

US Brand Names

HALFAN® (DISCONTINUED)

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied

Mechanism of Action

The mechanism of action of halofantrine is unknown.

References